Iida K, Naiki T, Etani T, Nagai T, et al. Proton pump inhibitors and potassium competitive acid blockers decrease pembrolizumab efficacy in patients with metastatic urothelial carcinoma. Sci Rep 2024;14:2520.
PMID: 38291115